首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   53142篇
  免费   4022篇
  国内免费   2507篇
耳鼻咽喉   258篇
儿科学   1495篇
妇产科学   505篇
基础医学   11826篇
口腔科学   390篇
临床医学   4002篇
内科学   14791篇
皮肤病学   590篇
神经病学   1247篇
特种医学   643篇
外国民族医学   7篇
外科学   2249篇
综合类   6614篇
现状与发展   19篇
预防医学   8894篇
眼科学   391篇
药学   2712篇
  14篇
中国医学   949篇
肿瘤学   2075篇
  2024年   58篇
  2023年   739篇
  2022年   2056篇
  2021年   2412篇
  2020年   1882篇
  2019年   1664篇
  2018年   1668篇
  2017年   1637篇
  2016年   1941篇
  2015年   2230篇
  2014年   3129篇
  2013年   3382篇
  2012年   3084篇
  2011年   3756篇
  2010年   3167篇
  2009年   2700篇
  2008年   2540篇
  2007年   2682篇
  2006年   2384篇
  2005年   2065篇
  2004年   1817篇
  2003年   1574篇
  2002年   1260篇
  2001年   1205篇
  2000年   978篇
  1999年   871篇
  1998年   762篇
  1997年   779篇
  1996年   635篇
  1995年   637篇
  1994年   601篇
  1993年   476篇
  1992年   357篇
  1991年   311篇
  1990年   274篇
  1989年   246篇
  1988年   238篇
  1987年   171篇
  1986年   144篇
  1985年   316篇
  1984年   192篇
  1983年   141篇
  1982年   129篇
  1981年   105篇
  1980年   73篇
  1979年   62篇
  1978年   52篇
  1977年   32篇
  1976年   31篇
  1974年   6篇
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
21.
LightCycler实时监测PCR定量分析血清HBV DNA   总被引:2,自引:0,他引:2  
目的 检验LightCycler实时监测PCR(real-time detection PCR,RTD-PCR)对血清中HBV DNA定量检测的灵敏性和可重复性,探讨HBV血清标志物与HBV DNA定量的关系。方法 HBV定量按深圳匹基公司乙肝PCR荧光检测试剂盒使用说明,对乙肝标志物已明确的773例血清中HBV DNA定量结果进行统计分析。结果 实时监测PCR对血清中HBV DNA定量检测的灵敏性高,可检测低至1000拷贝/ml血清;可重复性好,批间误差<20%;各种标志物类型的血清HBV DNA含量分布情况表明,HBV血清标志物中HBeAg与HBV DNA含量有明显的关系,一般HBeAg阳性血清HBV DNA含量较高,但也有相当一部分例外。结论 LightCycler实时监测PCR对血清中HBV DNA定量检测灵敏性高可重复性好;仅根据HBV血清标志物往往不能确定乙肝患者HBV DNA复制水平的高低,HBV DNA定量检测具有十分重要的临床意义。  相似文献   
22.
We correlated MRI features with histopathological findings in an HIV-positive patient with vacuolar myelopathy. On MRI symmetrical nonenhancing high-signal areas in the posterior columns on T2-weighted images result from extensive vacuolation visible on histological sections. Received: 18 November 1997 Accepted: 23 March 1997  相似文献   
23.
Abstract Human immunodeficiency virus (HIV)-l neuropathogenesis can be divided into three important components: (i) virus entry into the nervous system; (ii) the role of viral proteins and/or cellular products in neural tissue damage; and (iii) the mechanisms of neuronal injury/death. Both blood derived macrophages or trafficking HIV-1 infected T-lymphocytes have been implicated in viral entry to the central nervous system (CNS). The major cell type harboring productive HIV-1 infection in the nervous system is the perivascular macrophage/ microglia. The HIV-1 infection of brain astrocytes, restricted to the expression of regulatory gene products, may cause astrocyte dysfunction and contribute to neuronal injury or to disruption of the blood-brain barrier (BBB). Studies of cerebrospinal fluid and postmortem tissues reveal chronic inflammation/immune activation in the nervous system during the later stages of HIV-1 infection associated with disruption of BBB integrity. Blood-brain barrier damage may underlie the white matter pallor described in HIV-1 infection and could result in further entry into the CNS of toxic viral or cellular products, or additional HIV-1 infected cells. The HIV infected and activated macrophages/microglia produce excessive amounts of pro-inflammatory cytokines, including tumor necrosis factor alpha, and platelet activating factor. These products are directly toxic to human neurons in vitro. The HIV-1 envelope glycoprotein, gp 120 may stimulate the release of toxic factors from brain macrophages. Blocking N-methyl-D-aspartate (NMDA; or AMPA) glutamate receptors can antagonize candidate toxins of both viral and cellular origin. It has been postulated that (weak) excitotoxicity leads to oxidative stress in neurons and ultimately to apoptosis. Neuronal apoptosis occurs in the brains of both children and adults with HIV-1 infection. This understanding of HIV neuropathogenesis implies that therapeutic strategies should include: (i) anti-retroviral medications to decrease systemic and CNS virus load, and possibly to prevent perinatal transmission of HIV; (ii) anti-inflammatory compounds to decrease the chronic immune activation in microglia and allow the restoration of BBB integrity; and (iii) neuroprotective compounds to reduce neuronal injury and apoptotic death.  相似文献   
24.
110例嗜酸细胞增多性非变应性鼻炎的液氮冷冻治疗山西医学院第二附属医院(030001)牛玉梅,刘学仁按Mggind将常年性鼻炎分为三类:一类常年性变态反应性鼻炎;二类非变态反应性鼻炎伴鼻分泌物嗜酸细胞增多综合征也叫嗜酸细胞增多性非变态反应性鼻炎(Eosinophilicnonalleraicrhinits,ENR);三类自主神经性常年性鼻炎[1]。我们将ENR中找不到致敏物,而与冷热空气有关与情绪无关的110例患者进行了液氮冷冻治疗。临床资料802例常年性鼻炎患者进行皮肤激发试验。437例找出了致敏物,进行特异性过敏诱因脱敏治疗或抗过敏药物治疗。365例试验阳性,其中有135例与冷热空气有关。ll0例行冷冻治疗。1l0例中男50例,女60例;年龄最大65岁,最小16岁。110例均有间歇性的连续喷嚏发作,浆液性或粘液性鼻分泌物增多和鼻粘膜非充血性肿胀引起的堵塞,无因吸入致敏原诱发症状的病史;血清IgE值不升高,特异性皮肤试验结果为阳性;鼻分泌物中嗜酸细胞阳性。方法:先将鼻腔内喷入1%地卡因溶液3次粘膜表面麻醉,用卷好的4厘米长、0.4~0.6厘米粗的棉棒沾上液氮在鼻镜直视下迅速插入鼻腔内。时间约1分钟左右(冷  相似文献   
25.
Antibodies against nerve growth factor (NGF) in sera were detected by enzyme-linked immunosorbent assays (ELISA), by their isolation after passage of sera through NGF immunoadsorbent columns and by their specificity to bind and immunoprecipitate mouse NGF as well as to stain by immunohistochemical methods cellular sites of NGF synthesis. Increased levels of anti-NGF antibodies were found in sera of herpes simplex virus (HSV)-infected patients but not in HSV-inoculated rabbits. As HSV latency is known to be promoted by NGF in vitro, these results may suggest that anti-NGF antibodies modulate the cytokine function of NGF and thus might play a role in HSV infection. The biological function of circulating antibodies against NGF, in general, is now open to future investigation.  相似文献   
26.
本文通过免疫荧光(IF)和电镜(EM)技术对新疆出血热(XHF)及流行性出血热(EHF)病毒的生物学特性在Vero E_6及LLC-MK_2两株传代细胞上进行了比较。两种病毒感染两株细胞后免疫荧光染色有两种不同的荧光形态特征,两种病毒对细胞的敏感性明显不同,XHF病毒在LLC-MK_2细胞上感染后6~8天可出现明显的细胞病变,而EHF病毒感染此细胞后则不引起病变。电镜观察到两种病毒在LLC-MK_2细胞中都能形成与布尼病毒相似的形态特征。  相似文献   
27.
Different doses of hepatitis B virus vaccine—prepared by Korea Green Cross Corporation, were given to healthy infants born to HBsAg-negative mothers at birth, 1 and 6 months of age. A dose of 2 μg was administered intradermally in Group A and, in the three other groups, the vaccine was given intramuscularly (i.m.). An adequate follow-up observation was possible for 9 months after birth in 22, 25, 23 and 21 infants in Groups A, B, C and D, respecvely.
Group C (5 μg, i.m.) produced seroconversion most rapidly, showing the highest rate (96%) at 9 months of age. The lowest seroconversion rate (5%) was found at the age of 1 month in Group A subjects, but the rate increased to 91% after a booster dose was given at 6 months of age.
While it can be concluded that a 5 μg i.m. dose of vaccine at 0, 1 and 6 months of age is optimum for the immunization of infants in efficacy and economy, a 2 μg intradermal dose can also be considered as an immunogenic and economical regimen, though the immune response is slower and a special technique is required for immunization.  相似文献   
28.
Summary.  Hepatitis B virus (HBV) circulates in blood as closely related, but genetically diverse molecules called quasispecies. During replication, HBV production may approach 1011 molecules/day, although during peak activity this rate may increase 100–1000 times. Generally, DNA polymerases have excellent fidelity in reading DNA templates because they are associated with an exonuclease which removes incorrectly added nucleotides. However, the HBV-DNA polymerase lacks fidelity and proofreading function partly because exonuclease activity is either absent or deficient. Thus, the HBV genome and especially the envelope gene, is mutated with unusually high frequency. These mutations can affect more than one open reading frame because of overlapping genes. The S gene contains an exposed major hydrophilic region (residues 110–155), which encompasses the 'a' determinant that is important for inducing immunity. Nucleotide substitutions in this region are common and result in reduced binding or failure to detect hepatitis B surface antigen (HBsAg) in diagnostic assays. Adaptive immunity also depends on the recognition of HBsAg by specific antibody and variants pose a threat if they interfere with binding to antibody. Finally, genomic hypervariability allows HBV to escape selection pressures imposed by antiviral therapies, vaccines and the host immune system, and is responsible for creating genotypes, subgenotypes and subtypes.  相似文献   
29.
With the introduction of more potent immunosuppressive agents, rejection has decreased in simultaneous pancreas/kidney transplant (SPK) recipients. However, as a consequence, opportunistic infections have increased. The purpose of this report is to outline the course of SPK patients who developed polyomavirus-associated nephropathy (PVAN). A retrospective review of 146 consecutive SPK recipients from January 1, 1996 to December 31, 2002 was performed. Immunosuppression, rejection and development of PVAN were reviewed. Nine patients were identified. All received induction with either OKT3 or thymoglobulin. Immunosuppression included tacrolimus/cyclosporine, MMF/azathioprine and sirolimus/prednisone. Two patients were treated for kidney rejection prior to the diagnosis of PVAN. Time to diagnosis was an average of 359.3 days post-transplantation. Immunosuppression was decreased but five ultimately lost function. However, none developed pancreatic abnormalities as demonstrated by normal glucose and amylase. Two underwent renal retransplantation after PVAN diagnosis and both have normal kidney function. PVAN was the leading cause of renal loss in SPK patients in the first 2 years after transplantation and is a serious concern for SPK recipients. The pancreas, however, is spared from evidence of infection, and no pancreatic rejection occurred when immunosuppression was decreased.  相似文献   
30.
The correlation between microscopic changes with cellular localization of viral antigens was studied in the ileum of 16 cases infected with bovine viral diarrhea virus (BVDV). Microscopic lesions in the ileum included multifocal erosive and ulcerative ileitis, severe congestion and hemorrhage, crypt dilation and mucus engorgement, epithelial debris and leukocytes, lymphoid depletion of Peyer’s patches, herniation of mucosal epithelium into depleted Peyer’s patches, and fibrinoid vasculitis of submucosal vessels. BVDV antigen was detected by immunohistochemistry in macrophages, dendritic cells, smooth muscle cells, endothelial cells, epithelial cells of crypts, and mucosal epithelium, together with other mononuclear cells including lymphocytes, plasma cells, fibroblasts, and intramural ganglial cells. No consistent correlation between the presence of BVDV antigen and vascular lesions in the ileum was identified. The intensity and distribution of the immunoperoxidase stain in the ileum was graded as highly positive (18.7%), moderately positive (56.3%), and mildly positive (25%). In conclusion, the pattern and density of distribution and localization of BVDV antigen in the ileum was not consistently correlated with the severity of microscopic lesions.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号